Clinical Trial Update: A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of VEC intravenous chemotherapy combined with Conbercept intravitreal injection for retinoblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Conbercept intravitreal injection
• VEC intravenous chemotherapy

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Retinoblastoma | Phase 2 | Status: UNKNOWN